UCSF Adult Restricted Antimicrobials

Maribavir

Restricted to ID or Antimicrobial Stewardship except:

1) Continuation of prior therapy

Meropenem/vaborbactam

Restricted to ID or Antimicrobial Stewardship except:

1) Continuation of prior therapy

Micafungin

Restricted to ID or Antimicrobial Stewardship except:

1) Documented sterile site (not urine or respiratory) infection  with microbiologically confirmed Candida glabrata or Candida kruseii

2) Documented sterile site infection (not urine or respiratory) infection with yeast, pending species identification

3) Prophylaxis against fungal infections in patients on the hematology/oncology/BMT service with intolerance of or contraindications to azoles

4) Empiric therapy for prolonged febrile neutropenia in hematology/oncology/BMT patient

Miltefosine

Restricted to ID or Antimicrobial Stewardship with exceptions:

1) Continuation of therapy 

Omadacycline

Oral formulation 

Restricted to ID or Antimicrobial Stewardship except:

1) Continuation of prior therapy

Oritavancin

Restricted to ID or Antimicrobial Stewardship 

Pentamidine IV

Restricted to ID or Antimicrobial Stewardship 

Peramivir

Restricted to ID or Antimicrobial Stewardship 

Plazomicin

Restricted to ID or Antimicrobial Stewardship 

Polymyxin B

Restricted to ID or Antimicrobial Stewardship 

Posaconazole

IV formulation - Restriced to ID or Antimicrobial Stewardship 

PO formulation - Restricted to ID or Antimicrobial Stewardship except:

1) Prophylaxis against fungal infections in patients on the hematology/BMT or lung transplant services with an intolerance of or contraindications to voriconazole

2) Suspected or documented fungal pneumonia in the hematology/BMT or lung transplant services

3) Empiric therapy for prolonged febrile neutropenia in hematology/oncology/BMT patient

Tedizolid

Restricted to ID or Antimicrobial Stewardship 

Tigecycline

Restricted to ID or Antimicrobial Stewardship 

Voriconazole

Restricted to ID or Antimicrobial Stewardship except:

1) Prophylaxis against fungal infections on the hematology/BMT/lung transplant services​

2) Suspected or documented fungal pneumonia in the hematology/BMT/lung transplant services​

3) Empiric therapy for prolonged febrile neutropenia in hematology/oncology/BMT patient

Pages